Biovie Inc Stock Investor Sentiment

BIVI Stock  USD 1.67  0.02  1.21%   
Under 65% of Biovie's investor base is looking to short. The analysis of the overall investor sentiment regarding Biovie Inc suggests that many traders are alarmed. Biovie's investing sentiment shows overall attitude of investors towards Biovie Inc.
  

Biovie Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Biovie can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at accesswire.com         
FINAL DEADLINE TODAY The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of 100,000 ...
news
over six months ago at prnewswire.com         
BioVie Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before ...
prnewswire News
over six months ago at accesswire.com         
BioVie Inc. Sued for Securities Law Violations - Contact Levi Korsinsky Before March 19, 2024 to Dis...
news
over six months ago at accesswire.com         
BioVie Inc. Sued for Securities Law Violations - Investors Should Contact Levi Korsinsky Before Marc...
news
over six months ago at benzinga.com         
BIVI INVESTOR ALERT Bronstein, Gewirtz Grossman LLC Announces that BioVie Inc. Investors with Substa...
benzinga news
over six months ago at accesswire.com         
Lost Money on BioVie Inc. Join Class Action Suit Seeking Recovery - Contact Levi Korsinsky
news
over six months ago at accesswire.com         
Shareholders that lost money on BioVie Inc. Urged to Join Class Action - Contact Levi Korsinsky to L...
news
over six months ago at accesswire.com         
Levi Korsinsky Reminds BioVie Inc. Investors of the Pending Class Action Lawsuit with a Lead Plainti...
news
over six months ago at benzinga.com         
BIVI 4-DAY DEADLINE ALERT Hagens Berman, National Trial Attorneys, Encourages BioVie Investors with ...
benzinga news
over six months ago at accesswire.com         
Shareholders that lost money on BioVie Inc. Urged to Join Class Action - Contact Levi Korsinsky to L...
news
over six months ago at businesswire.com         
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit A...
businesswire News
over six months ago at businesswire.com         
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit A...
businesswire News
over six months ago at accesswire.com         
BioVie Inc. Class Action Levi Korsinsky Reminds BioVie Investors of the Pending Class Action Lawsuit...
news
over six months ago at accesswire.com         
FINAL DEADLINE TOMORROW The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of 100,0...
news
over six months ago at benzinga.com         
BIOVIE DEADLINE ALERT Bragar Eagel Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Be...
benzinga news
Far too much social signal, news, headlines, and media speculation about Biovie that are available to investors today. That information is available publicly through Biovie media outlets and privately through word of mouth or via Biovie internal channels. However, regardless of the origin, that massive amount of Biovie data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biovie news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biovie relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biovie's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biovie alpha.

Biovie Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
BioVies Upcoming Parkinsons Disease Clinical Trial is Fully Funded
11/04/2024
2
Acquisition by Berman Richard J of 51830 shares of Biovie subject to Rule 16b-3
11/07/2024
3
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
11/20/2024
4
Acquisition by Do Cuong V of 104502 shares of Biovie at 1.9 subject to Rule 16b-3
12/20/2024
5
Acquisition by Rogich Sigmund of 123400 shares of Biovie at 5.04 subject to Rule 16b-3
12/27/2024
6
BioVie Leaders Sued for Stock Slips on Clinical Trial Misconduct - Bloomberg Law
12/31/2024
7
BioVie Inc. Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, ...
01/13/2025

Complementary Tools for Biovie Stock analysis

When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios